Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2015, Article ID 518639, 8 pages
http://dx.doi.org/10.1155/2015/518639
Research Article

Qizhi Jiangtang Jiaonang Improves Insulin Signaling and Reduces Inflammatory Cytokine Secretion and Reactive Oxygen Species Formation in Insulin Resistant HepG2 Cells

1Department of Pathogenobiology, The Key Laboratory of Zoonosis, Chinese Ministry of Education, College of Basic Medicine, Jilin University, Changchun, Jilin 130021, China
2Jilin Yizheng Pharmaceutical Group Co., Ltd., Siping, Jilin 136001, China
3The Second Department of Cardiology, The people’s Liberation Army No. 208 Hospital, Changchun, Jilin 130021, China

Received 9 December 2014; Revised 16 April 2015; Accepted 21 April 2015

Academic Editor: I-Min Liu

Copyright © 2015 Xiao-Tian Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. World Health Organization, Diabetes Fact Sheet No. 312, 2011.
  2. K. Cusi, “The role of adipose tissue and lipotoxicity in the pathogenesis of type 2 diabetes,” Current Diabetes Reports, vol. 10, no. 4, pp. 306–315, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. N. Sattar and J. M. Gill, “Type 2 diabetes as a disease of ectopic fat?” BMC Medicine, vol. 12, no. 1, article 123, 2014. View at Publisher · View at Google Scholar
  4. M. F. White, “The insulin signalling system and the IRS proteins,” Diabetologia, vol. 40, supplement 2, pp. S2–S17, 1997. View at Publisher · View at Google Scholar · View at Scopus
  5. P. Cohen, D. R. Alessi, and D. A. E. Cross, “PDK1, one of the missing links in insulin signal transduction?” FEBS Letters, vol. 410, no. 1, pp. 3–10, 1997. View at Publisher · View at Google Scholar · View at Scopus
  6. A. He, X. Liu, L. Liu, Y. Chang, and F. Fang, “How many signals impinge on GLUT4 activation by insulin?” Cellular Signalling, vol. 19, no. 1, pp. 1–7, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. R. M. Sargis, “The hijacking of cellular signaling and the diabetes epidemic: mechanisms of environmental disruption of insulin action and glucose homeostasis,” Diabetes & Metabolism Journal, vol. 38, no. 1, pp. 13–24, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Yamaguchi, T. Nishimura, H. Ishiba et al., “Blockade of interleukin 6 signalling ameliorates systemic insulin resistance through upregulation of glucose uptake in skeletal muscle and improves hepatic steatosis in high-fat diet fed mice,” Liver International, vol. 35, no. 2, pp. 550–561, 2015. View at Publisher · View at Google Scholar
  9. D. Umpierre, P. A. B. Ribeiro, C. K. Kramer et al., “Physical activity advice only or structured exercise training and association with HbA1c levels in type 2 diabetes: a systematic review and meta-analysis,” Journal of the American Medical Association, vol. 305, no. 17, pp. 1790–1799, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. D. Thomas and E. J. Elliott, “Low glycaemic index, or low glycaemic load, diets for diabetes mellitus,” Cochrane Database of Systematic Reviews, no. 1, Article ID CD006296, 2009. View at Google Scholar · View at Scopus
  11. E. Zintzaras, M. Miligkos, P. Ziakas et al., “Assessment of the relative effectiveness and tolerability of treatments of type 2 diabetes mellitus: a network meta-analysis,” Clinical Therapeutics, vol. 36, no. 10, pp. 1443.e9–1453.e9, 2014. View at Publisher · View at Google Scholar
  12. C. Merlotti, A. Morabito, V. Ceriani, and A. E. Pontiroli, “Prevention of type 2 diabetes in obese at-risk subjects: a systematic review and meta-analysis,” Acta Diabetologica, vol. 51, no. 5, pp. 853–863, 2014. View at Google Scholar
  13. P. Subash-Babu, S. Ignacimuthu, and A. A. Alshatwi, “Nymphayol increases glucose-stimulated insulin secretion by RIN-5F cells and GLUT4-mediated insulin sensitization in type 2 diabetic rat liver,” Chemico-Biological Interactions, vol. 226, pp. 72–81, 2015. View at Publisher · View at Google Scholar
  14. M. Li, W. Wang, J. Xue, Y. Gu, and S. Lin, “Meta-analysis of the clinical value of Astragalus membranaceus in diabetic nephropathy,” Journal of Ethnopharmacology, vol. 133, no. 2, pp. 412–419, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Zhang, X. Xie, C. Li, and P. Fu, “Systematic review of the renal protective effect of Astragalus membranaceus (root) on diabetic nephropathy in animal models,” Journal of Ethnopharmacology, vol. 126, no. 2, pp. 189–196, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. T. Y. C. Poon, K. L. Ong, and B. M. Y. Cheung, “Review of the effects of the traditional Chinese medicine Rehmannia Six Formula on diabetes mellitus and its complications,” Journal of Diabetes, vol. 3, no. 3, pp. 184–200, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. Q. Zhang, F. Wei, C. C. Fong et al., “Transcriptional profiling of human skin fibroblast cell line Hs27 induced by herbal formula Astragali Radix and Rehmanniae Radix,” Journal of Ethnopharmacology, vol. 138, no. 3, pp. 668–675, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. X.-Q. Mao, F. Yu, N. Wang et al., “Hypoglycemic effect of polysaccharide enriched extract of Astragalus membranaceus in diet induced insulin resistant C57BL/6J mice and its potential mechanism,” Phytomedicine, vol. 16, no. 5, pp. 416–425, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. N. Kim, H. M. Kim, E. S. Lee et al., “Dibenzoylmethane exerts metabolic activity through regulation of AMP-activated protein kinase (AMPK)-mediated glucose uptake and adipogenesis pathways,” PLOS ONE, vol. 10, no. 3, Article ID e0120104, 2015. View at Publisher · View at Google Scholar
  20. M. Liu, K. Wu, X. Mao, Y. Wu, and J. Ouyang, “Astragalus polysaccharide improves insulin sensitivity in KKAy mice: regulation of PKB/GLUT4 signaling in skeletal muscle,” Journal of Ethnopharmacology, vol. 127, no. 1, pp. 32–37, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Liu, J. Bai, X. Weng, T. Wang, and M. Li, “Amelioration of insulin resistance in rat cells by Astragalus polysaccharides and associated mechanisms,” Experimental and Therapeutic Medicine, vol. 7, no. 6, pp. 1599–1604, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. L.-M. Guo, R.-X. Zhang, Z.-P. Jia, M.-X. Li, J. Wang, and Q. Yin, “Effects of Rehmannia glutinosa oligosaccharides on proliferation of HepG2 and insulin resistance,” China Journal of Chinese Materia Medica, vol. 32, no. 13, pp. 1328–1332, 2007 (Chinese). View at Google Scholar · View at Scopus
  23. X.-F. Lv, Q.-Y. Meng, and X.-M. Guo, “Effect of Rehmannia glutinosa water extraction on insulin resistance and gene expression of resistin in type 2 diabetes mellitus rats,” Zhongguo Zhongyao Zazhi, vol. 32, no. 20, pp. 2181–2184, 2007 (Chinese). View at Google Scholar · View at Scopus
  24. Y. Li, Y. C. Jiang, Z. A. Guo et al., “Effect of Qizhi Jiangtang capsule on the ratio of intima/media thickness and inflammatory factors in renal small artery of diabetic nephropathy rats,” Chinese Journal of Integrated Traditional and Western Nephrology, no. 10, pp. 858–863, 2013, (Chinese). View at Google Scholar
  25. Y. Luo, P. Rana, and Y. Will, “Palmitate increases the susceptibility of cells to drug-induced toxicity: an in vitro method to identify drugs with potential contraindications in patients with metabolic disease,” Toxicological Sciences, vol. 129, no. 2, pp. 346–362, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. F. Delaere, C. Magnan, and G. Mithieux, “Hypothalamic integration of portal glucose signals and control of food intake and insulin sensitivity,” Diabetes and Metabolism, vol. 36, no. 4, pp. 257–262, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. N. Hariharan, D. Farrelly, D. Hagan et al., “Expression of human hepatic glucokinase in transgenic mice liver results in decreased glucose levels and reduced body weight,” Diabetes, vol. 46, no. 1, pp. 11–16, 1997. View at Publisher · View at Google Scholar · View at Scopus
  28. M. S. Winzell, M. Coghlan, B. Leighton et al., “Chronic glucokinase activation reduces glycaemia and improves glucose tolerance in high-fat diet fed mice,” European Journal of Pharmacology, vol. 663, no. 1–3, pp. 80–86, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. L. F. Rezende, R. L. Camargo, R. C. Branco, A. P. Cappelli, A. C. Boschero, and E. M. Carneiro, “Reduced insulin clearance and lower insulin-degrading enzyme expression in the liver might contribute to the thrifty phenotype of protein-restricted mice,” British Journal of Nutrition, vol. 112, no. 6, pp. 900–907, 2014. View at Publisher · View at Google Scholar
  30. J. Z. Ma, L. X. Yang, X. L. Shen et al., “Effects of traditional Chinese medicinal plants on anti-insulin resistance bioactivity of DXMS-induced insulin resistant HepG2 cells,” Natural Products and Bioprospecting, vol. 4, no. 4, pp. 197–206, 2014. View at Publisher · View at Google Scholar
  31. M. Zhao, Z.-F. Zhang, Y. Ding, J.-B. Wang, and Y. Li, “Astragalus polysaccharide improves palmitate-induced insulin resistance by inhibiting PTP1B and NF-κB in C2C12 myotubes,” Molecules, vol. 17, no. 6, pp. 7083–7092, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. Y. Zhang, J. Hai, M. Cao et al., “Silibinin ameliorates steatosis and insulin resistance during non-alcoholic fatty liver disease development partly through targeting IRS-1/PI3K/Akt pathway,” International Immunopharmacology, vol. 17, no. 3, pp. 714–720, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. C. H. Chung, M. Y. Lee, R. Choi et al., “Peroxisome proliferator-activated receptor δ agonist attenuates hepatic steatosis by anti-inflammatory mechanism,” Experimental & Molecular Medicine, vol. 44, no. 10, pp. 578–585, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. Y. J. Choi, S. E. Choi, E. S. Ha et al., “Involvement of visfatin in palmitate-induced upregulation of inflammatory cytokines in hepatocytes,” Metabolism: Clinical and Experimental, vol. 60, no. 12, pp. 1781–1789, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. W. Chen, Y.-M. Li, and M.-H. Yu, “Astragalus polysaccharides: an effective treatment for diabetes prevention in NOD mice,” Experimental and Clinical Endocrinology & Diabetes, vol. 116, no. 8, pp. 468–474, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. V. Y. Waisundara, M. Huang, A. Hsu, D. Huang, and B. K.-H. Tan, “Characterization of the anti-diabetic and antioxidant effects of rehmannia glutinosa in streptozotocin-induced diabetic Wistar rats,” The American Journal of Chinese Medicine, vol. 36, no. 6, pp. 1083–1104, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. D. Gao, S. Nong, X. Huang et al., “The effects of palmitate on hepatic insulin resistance are mediated by NADPH Oxidase 3-derived reactive oxygen species through JNK and p38MAPK pathways,” The Journal of Biological Chemistry, vol. 285, no. 39, pp. 29965–29973, 2010. View at Publisher · View at Google Scholar · View at Scopus